BAK-LOSS LETHAL PROSTATE CANCER: UNCOVERING THERAPEUTIC VULNERABILITIES TO DELIVER NEW TREATMENTS AND IMPROVE CLINICAL OUTCOMES

Institute Of Cancer Research: Royal Cancer Hospital (The)

Investigators